23 results on '"Novo Nordisk A/S -- Reports"'
Search Results
2. Type 1 Diabetes Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
3. Hemophilia A Pipeline Assessment 2024: FDA Approvals, Drugs, Therapies and Companies by DelveInsight | Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, Pfizer, Sanofi Genzyme, Novo Nordisk
4. Chronic Kidney Disease Competitive Landscape Report 2023 (Updated) | Boehringer Ingelheim, Eli Lilly, Reata Pharma, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharma, and others
5. Monoclonal Antibodies: Competitive Landscape Report, 2023 Featuring Insights of Novartis, Gmax Biopharm, Omeros Corp, and Merck Sharp & Dohme Among ~180 Other Players
6. Acquired Hemophilia A Pipeline constitutes 10+ key companies continuously working towards developing 10+ Acquired Hemophilia A treatment therapies, Analyzes DelveInsight
7. Hemophilia Pipeline Analysis: 80+ Companies are Working to Improve the Treatment Space | DelveInsight
8. Human Growth Hormone Market Is Boosting Up Economy With 8.2% CAGR, Owing To Rising Awareness For Diagnosis And Treatment of Growth Hormone Disorders Till 2027 | Grand View Research, Inc
9. Global Insulin Pens Market Outlook & Forecast Report 2022-2027 Featuring Leading Vendors - Lilly, Medtronic, Novo Nordisk, and Sanofi
10. Outlook on the Protein Therapeutics Global Market to 2026 - by Product, Therapy Area, Function and Region
11. Diabetes Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Daewoong Tradipitant, Janssen Biotech, Zealand Pharma, Provention Bio, ImCyse, Novo Nordisk, Enthera, ActoBio Th
12. Sickle Cell Disease Pipeline Analysis, unmet needs, opportunities, Key Players: Sanofi, Pfizer, Bristol Myers Squibb, Gilead Sciences, Novo Nordisk and Many More
13. Obesity Market Spotlight 2019: 10-year Disease Prevalence Forecast, Licensing and Acquisition Deals, Drug-specific Revenue Forecasts
14. Clinical Trials Market Advance & Cost Effective Technology 2019 to 2023 - By Industry Size, Share, Company Profiles, Impressive Growth, Demand, Latest Research & Future Profit
15. Corporate Reputation of Pharma in 2018 from Bleeding Disorders Patients: The Views of 27 Patient Groups of Bayer, CSL Behring, Grifols, Novo Nordisk, Octapharma, Pfizer, Roche, Takeda/Shire
16. Global Diabetes Market 2019 - Industry Analysis, Size, Share, Key Players, Applications, Strategies and Forecast to 2023
17. 2019 Anti-Obesity Drugs Report: Global Market Analysis, Trends and Forecasts Through 2015-2024
18. Contraceptives Drugs Market 2019 Global Industry Trends, Sales, Supply, Consumption, Demand, Analysis and Forecasts to 2025
19. Investigation Report on China's Insulin Detemir Market, 2018-2022
20. Insulin Delivery Devices Market by Syringe, Pumps, Pens, Jet Injectors and Forecasts Till 2020
21. Global Diabetes Pen Market Organization Size, Top Manufacturers, Service Providers, Solutions Forecast to 2021
22. Pharmaceuticals Manufacturers (Global) - Industry Report 2016: Individual Analysis of the Top 90 Companies Including Pfizer Inc, Novo Nordisk A/S & Allergan Inc
23. New Forecast Report - Latin America Insulin Market Size 2020: Radiant Insights, Inc
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.